Merck (MRK) Income towards Parent Company (2009 - 2026)
Merck's Income towards Parent Company was -$1.34 billion in Q2 2026, compared with $4.43 billion a year earlier.
Merck (MRK) Income towards Parent Company (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Merck's Income towards Parent Company was $3.17 billion through Jun 30, 2026, down 80.7% year-over-year; for FY2025, it was $18.25 billion, up 6.6% from FY2024.
- Income towards Parent Company shows a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
- In earlier years, Income towards Parent Company was $17.12 billion in FY2024, $365 million in FY2023 (-97.5%), $14.52 billion in FY2022 (+11.3%) and $13.05 billion in FY2021 (+84.6%).
- Quarterly Income towards Parent Company has moved between -$5.98 billion (Q2 2023) and $5.79 billion (Q3 2025) over five years.
- Compared with a year earlier, Income towards Parent Company was higher in two of the last five quarters, with growth averaging 3.3%.
- The best year-over-year quarter for Income towards Parent Company over five years was Q2 2022 (growth of 155.3%); the worst was Q1 2023 (a decline of 34.5%).
- Per Business Quant data, MRK's Income towards Parent Company in the three quarters before Q2 2026 was -$4.24 billion (Q1 2026), $2.96 billion (Q4 2025) and $5.79 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.34 Bn |
| Mar 31, 2026 | -4.24 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 5.79 Bn |
| Jun 30, 2025 | 4.43 Bn |
| Mar 31, 2025 | 5.08 Bn |
| Dec 31, 2024 | 3.74 Bn |
| Sep 30, 2024 | 3.16 Bn |
| Jun 30, 2024 | 5.46 Bn |
| Mar 31, 2024 | 4.76 Bn |
| Dec 31, 2023 | -1.23 Bn |
| Sep 30, 2023 | 4.75 Bn |
| Jun 30, 2023 | -5.98 Bn |
| Mar 31, 2023 | 2.82 Bn |
| Dec 31, 2022 | 3.02 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.94 Bn |
| Mar 31, 2022 | 4.31 Bn |
| Dec 31, 2021 | 3.76 Bn |
| Sep 30, 2021 | 4.57 Bn |
Merck Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=MRK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();